Status - Institut für angewandte Erkenntnistheorie und medizinische

IFAEMM e. V. Modellprojekt Anthroposophische Medizin: Abschlussbericht Seite 527 von 534
739. Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack
frequency and duration. Neurology 1994;44(6 Suppl 4):S24-S39.
740. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based
studies. Neurology 1994;44(6 Suppl 4):S17-S23.
741. Stucki G, Meier D, Stucki S, Michel BA, Tyndall AG, Dick W, Theiler R. Evaluation einer deutschen
Version des WOMAC (Western Ontario und McMaster Universities) Arthroseindex. Z Rheumatol
1996;55(1):40-49.
742. Stucki G, Stucki S, Sangha O. Patienten-zentrierte Evaluation der Krankheitsauswirkungen bei
muskuloskelettalen Erkrankungen: Adaptation und Neu-Entwicklung von Outcome-Instrumenten. Z
Rheumatol 1997;56(5):266-275.
743. Sturzenegger M. Lumbalgie - wie weiter? Ther Umsch 1993;50(11):737-745.
744. Suarez-Almazor ME, Kendall C, Johnson JA, Skeith K, Vincent D. Use of health status measures in
patients with low back pain in clinical settings. Comparison of specific, generic and preference-based
instruments. Rheumatology (Oxford) 2000;39(7):783-790.
745. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention
of death from asthma. N Engl J Med 2000;343(5):332-336.
746. Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies
M, Elliott GR, Greenhill LL, et al. Clinical relevance of the primary findings of the MTA: success
rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child
Adolesc Psychiatry 2001;40(2):168-179.
747. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. Attention-deficit
hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351(9100):429-433.
748. Sykes DA, Wilson R, Chan KL, Mackay IS, Cole PJ. Relative importance of antibiotic and improved
clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet
1986;2(8503):359-360.
749. Tamam L, Ozpoyraz N. Selective serotonin reuptake inhibitor discontinuation syndrome: a review.
Adv Ther 2002;19(1):17-26.
750. Tasche MJ, Uijen JH, Bernsen RM, de Jongste JC, van der Wouden JC. Inhaled disodium cromoglycate
(DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax
2000;55(11):913-920.
751. Tattersfield AE, Harrison TW. Low-dose budesonide for asthma. Lancet 2003;361:1066-1067.
752. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002;360(9342):1313-1322.
753. Tautz C. Kindliches Asthma bronchiale. Der Merkurstab 1996;49(5):422-424.
754. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk
factors for adolescent development. J Am Acad Child Adolesc Psychiatry 1996;35(9):1213-1226.
755. Teresi LM, Lufkin RB, Reicher MA, Moffit BJ, Vinuela FV, Wilson GM, Bentson JR, Hanafee WN.
Asymptomatic degenerative disk disease and spondylosis of the cervical spine: MR imaging. Radiology
1987;164(1):83-88.
756. Tfelt-Hansen P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P, Diener H, Schoenen J,
Ferrari MD, Goadsby PJ. Ergotamine in the acute treatment of migraine: a review and European
consensus. Brain 2000;123 ( Pt 1):9-18.
757. Thase ME, Greenhouse JB, Frank E, Reynolds CF, III, Pilkonis PA, Hurley K, Grochocinski V,
Kupfer DJ. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy
combinations. Arch Gen Psychiatry 1997;54(11):1009-1015.
758. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide
or nedocromil in children with asthma. N Engl J Med 2000;343(15):1054-1063.
759. The UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders:
a systematic review and meta-analysis. Lancet 2003;361:799-808.